VivoSim Labs Prices Public Offering of Common Stock and Warrants for Gross Proceeds up to $4 Million
VivoSim Labs announced the pricing of a best efforts public offering of up to 3,508,772 shares of common stock and accompanying warrants. The offering is comprised of two tranches, with the initial tranche closing on April 1, 2026, and is expected to generate gross proceeds of up to $4 million, which will provide the company with additional capital.
Key Highlights
- Priced a best efforts public offering of up to 3,508,772 shares of common stock or pre-funded warrants.
- Each share/warrant is sold with 1.5 common warrants to purchase one share of common stock.
- Initial Tranche closed on April 1, 2026, issuing 286,557 shares and 2,345,022 pre-funded warrants.
- Combined public offering price of $1.14 per share and $1.139 per pre-funded warrant.
- Each Common Warrant issued in the Initial Tranche has an exercise price of $1.71 per share of Common Stock.
Price Impact
More from VIVS
More in Equity Offering
One & one Green Technologies Secures $13M in Follow-on Offering from Institutional Investors, with Option for Additional $3M
Linkers Industries Completes Full Exercise of Series B Cashless Warrants, Resulting in 1.52M Class A Shares Outstanding
Annovis Bio Secures $10M Public Offering, Extends Cash Runway to Q2 2027, Funds NDA Submission with AD Phase 3 Trial 75% Enrolled